Trials / Unknown
UnknownNCT00980304
R Retreatment in 1st Relapsed DLBCL
A Multicenter, Open Label, Phase II Trial of Rituximab in Combination With ICE as Salvage Therapy in the Relapsed DLBCL Patients After 1st Line Induction Treatment of 6-8 Cycles of RCHOP-LIKE Chemo
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
It is a phase II , multicenter, open label clinical trial. Only the relapsed DLBCL patients after 1st line induction treatment of 6\~8 cycles of RCHOP-like chemo will be enrolled to receive 3 cycles of RICE as salvage therapy. After treatment each patient should be followed up for 2 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rituximab |
Timeline
- First posted
- 2009-09-21
- Last updated
- 2009-09-21
Source: ClinicalTrials.gov record NCT00980304. Inclusion in this directory is not an endorsement.